» Articles » PMID: 29135058

Distinct Features of Multivesicular Body-lysosome Fusion Revealed by a New Cell-free Content-mixing Assay

Overview
Journal Traffic
Publisher Wiley
Specialties Biology
Physiology
Date 2017 Nov 15
PMID 29135058
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

When marked for degradation, surface receptor and transporter proteins are internalized and delivered to endosomes where they are packaged into intralumenal vesicles (ILVs). Many rounds of ILV formation create multivesicular bodies (MVBs) that fuse with lysosomes exposing ILVs to hydrolases for catabolism. Despite being critical for protein degradation, the molecular underpinnings of MVB-lysosome fusion remain unclear, although machinery underlying other lysosome fusion events is implicated. But how then is specificity conferred? And how is MVB maturation and fusion coordinated for efficient protein degradation? To address these questions, we developed a cell-free MVB-lysosome fusion assay using Saccharomyces cerevisiae as a model. After confirming that the Rab7 ortholog Ypt7 and the multisubunit tethering complex HOPS (homotypic fusion and vacuole protein sorting complex) are required, we found that the Qa-SNARE Pep12 distinguishes this event from homotypic lysosome fusion. Mutations that impair MVB maturation block fusion by preventing Ypt7 activation, confirming that a Rab-cascade mechanism harmonizes MVB maturation with lysosome fusion.

Citing Articles

Four distinct cytoplasmic structures generate and release specific vesicles, thus opening the way to intercellular communication.

Racchetti G, Meldolesi J Extracell Vesicles Circ Nucl Acids. 2024; 4(1):44-58.

PMID: 39698300 PMC: 11648438. DOI: 10.20517/evcna.2023.03.


Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency.

Rene C, Parks R Mol Ther Methods Clin Dev. 2024; 32(2):101259.

PMID: 38770107 PMC: 11103572. DOI: 10.1016/j.omtm.2024.101259.


Current and novel approaches in yeast cell death research.

Chaves S, Rego A, Santos-Pereira C, Sousa M, Corte-Real M Cell Death Differ. 2024; 32(2):207-218.

PMID: 38714881 PMC: 11802841. DOI: 10.1038/s41418-024-01298-2.


Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design.

El Safadi D, Mokhtari A, Krejbich M, Lagrave A, Hirigoyen U, Lebeau G Vaccines (Basel). 2024; 12(3).

PMID: 38543914 PMC: 10974137. DOI: 10.3390/vaccines12030280.


Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond.

Palacio P, Pleet M, Reategui E, Magana S J Neuroimmunol. 2023; 377:578064.

PMID: 36934525 PMC: 10124134. DOI: 10.1016/j.jneuroim.2023.578064.